Beneficência Portuguesa de São Paulo
Beneficência Portuguesa de São Paulo
R. Maestro Cardim, 637 - Bela Vista, São Paulo - SP, 01323-001
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Larissa Rodrigues
Fabio Schutz
Raissa Carvalho
Murilo de Almeida Luz
Ana Carolina Badaró
Ligia Fernandes dos Santos Silva
Fellipe Gonçalves
Mariane Guerubim
Lucas Imanishi
Karla Kobal
Fabio Lewin
Rodrigo Mariano
Beatriz Morena
Stefane Silva
Tatiane Souza
Fabrício Vensol
Camila Yamada
Rosely Yamamura
Open studies
Lung cancer
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) - CodeBreaK 202 - AmgenSee more
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) - CodeBreaK 202 - AmgenSee more
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104). - AmgenSee more
Non-Hodgkin Lymphoma
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - BRUIN-CLL-314 - Loxo Oncology, Inc.See more
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - BRUIN-CLL-314 - Loxo Oncology, Inc.See more
Leukemia
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - BRUIN-CLL-314 - Loxo Oncology, Inc.See more
Bladder Cancer
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer - MoonRISe-3 - Janssen Research & Development, LLCSee more
Ovarian cancer
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) - DO-01 - Daiichi SankyoSee more
Multiple myeloma
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments - MAGNETISMM-5 - PfizerSee more
Colorectal cancer
Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait - CCHOWW - Hospital Alemão Oswaldo CruzSee more
Myeloproliferative syndromes
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis - KER-050 - Keros Therapeutics, Inc.See more
